Pharma Company Pipelines

Here’s a new site that I’ve been working on that takes you straight to company development pipelines without having to figure out where they are hiding. Not so much of a problem for small companies I know – but with the larger companies it’s not always obvious where the development pipeline is located

PharmaCompanyPipelines.com

Please let me know if you have other suggestions or find broken links (email is at the bottom of the page.

I’ll be making it a little more functional shortly – but currently I am dealing with some hosting issues

More interesting websites to come soon….keep tuned in

2007 Drug Approvals

Somewhat late in the posting but heres a list of 2007 US Drug approvals

Milken Inst Report on the Financial Impact of Chronic Disease

Interesting report on the cost of Chronic Disease (Free)

Google Date range searching

Have you ever tried Google’s date range searching and been annoyed with the results – did it come up with old pages when you only wanted recent ones? I certainly did and stopped ever using date range searching. Hopefully thats a thing of the past now though. As of May this year Google changed the date range syntax slightly. Before Google date marked a page when it was added to the Index AND whenever it was refreshed in the Index, i.e. when it gets reindexed. Now things have changes so that a webpage is only found on one date only – the one when it was originally added to Google’s index.

What does this mean? Well if you were searching for stories on, lets say, HIV Integrase inhibitors, now you only get webpages that were created in the last 3 months, as opposed to news stories that were published 5 years ago and are part of a web page that was updated in the last 3 months. It’s not fail safe – after all maybe Google, for whatever reason, only recently indexed an old page for the first time in the last 3 months, but on the whole it seems to work pretty well.

Symyx to acquire MDL

News for all the chemists out there is that Elsevier have sold MDL to Symyx
(including Beilstein/Crossfire) .

What does that mean? Well I guess it may lead to better bench tools for chemists and better integration with lab hardware/software. Will it mean less emphasis on database development? Possibly though MDL’s databases never seemed to be big sellers somehow (with the exception of Beilstein of course).

I’ve always thought that MDL interfaces could do with some cleaning up and modernization (not that I have had much of a change to play with Discoverygate which of course is their web interface) so hopefully with a better understanding of the needs of bench chemist’s that’s what Symyx will do.
MDL never seemed a terribly good fit with Elsevier somehow whose primary markets are not chemists.  Time will tell if it turns out to be better or worse for customers.